Product Information
ATOVAQUONE 750 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.7185 per ML under NDC 70748029901. Its NADAC has been published 232 times since Oct 27, 2021.
The High Outlier badge above means this manufacturer's average price in the ATOVAQUONE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748029901
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
3/18/2026
Active Ingredients
ATOVAQUONEApproval Type
Generic (ANDA)
FDA Application
ANDA210692On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE 750 MG/5 ML SUSP has been published 232 times since Oct 27, 2021, and over the history we have for it it has declined 33.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7185 per ML |
|---|---|
| All-time high | $1.3189 (Nov 16, 2022) |
| All-time low | $0.6984 (Nov 20, 2024) |
| 52-week high | $0.8766 |
| 52-week low | $0.7185 |
| Median price | $0.9525 |
| Average price | $0.9525 |
| Largest weekly change | +39.0% (Sep 21, 2022) |
| Weeks tracked | 232 |
| Tracking since | Oct 27, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.7185 per ML (NDC 70748029901), effective Apr 1, 2026.
How has the price of ATOVAQUONE 750 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has declined 33.9%. It has been tracked across 232 weekly CMS publications since Oct 27, 2021.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP?
Since Oct 27, 2021, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has ranged from a low of $0.6984 (Nov 20, 2024) to a high of $1.3189 (Nov 16, 2022), with a median of $0.9525 per ML.
Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ATOVAQUONE 750 MG/5 ML SUSP, is $0.7030 per ML — about 2% below ATOVAQUONE 750 MG/5 ML SUSP.
Who manufactures ATOVAQUONE 750 MG/5 ML SUSP?
ATOVAQUONE 750 MG/5 ML SUSP (NDC 70748029901) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification